Oracle Protects Healthcare Customers Against Cyberattacks
PRNewswire (Tue, 23-Apr 4:15 PM ET)
Oracle Helps Healthcare Organizations Solve Critical Supply Chain, HR, and Finance Challenges
PRNewswire (Tue, 23-Apr 8:00 AM ET)
Major Global Businesses Adopt Oracle Database@Azure Worldwide
PRNewswire (Tue, 23-Apr 8:00 AM ET)
Top high growth investment ratio stocks from each sector - GS
Seeking Alpha News (Mon, 22-Apr 4:25 PM ET)
Goldman’s debt issuers stocks basket
Seeking Alpha News (Mon, 22-Apr 12:53 PM ET)
Benzinga (Mon, 22-Apr 10:20 AM ET)
Auxilio Mutuo Hospital Selects Oracle Health's EHR to Improve Patient Experience
PRNewswire (Mon, 22-Apr 8:15 AM ET)
Oracle Cloud Secret Impact Level 6 Regions for U.S. Department of Defense
PRNewswire (Mon, 22-Apr 8:00 AM ET)
Oracle Cloud Service Enables Banks to Manage Climate Change Risk Across Portfolios
PRNewswire (Mon, 22-Apr 8:00 AM ET)
Benzinga (Fri, 19-Apr 7:28 AM ET)
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Oracle trades on the NYSE stock market under the symbol ORCL.
As of April 23, 2024, ORCL stock price climbed to $115.09 with 5,080,581 million shares trading.
ORCL has a beta of 1.21, meaning it tends to be more sensitive to market movements. ORCL has a correlation of 0.22 to the broad based SPY ETF.
ORCL has a market cap of $316.37 billion. This is considered a Mega Cap stock.
Last quarter Oracle reported $11 billion in Revenue and $1.41 earnings per share. This fell short of revenue expectation by $-2 billion and exceeded earnings estimates by $.03.
In the last 3 years, ORCL stock traded as high as $132.77 and as low as $60.78.
The top ETF exchange traded funds that ORCL belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
ORCL has underperformed the market in the last year with a price return of +22.6% while the SPY ETF gained +24.3%. ORCL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +4.9% and -6.8%, respectively, while the SPY returned +4.9% and -2.5%, respectively.
ORCL support price is $112.84 and resistance is $116.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ORCL stock will trade within this expected range on the day.